Brief: Navidea Signs Binding Framework For Commercialization Partnership With Jubilant Radiopharma
Aug 10 (Reuters) - Jubilant Life Sciences Ltd JULS.NS :
* NAVIDEA BIOPHARMACEUTICALS SIGNS BINDING FRAMEWORK FOR
COMMERCIALIZATION PARTNERSHIP WITH JUBILANT RADIOPHARMA
* NAVIDEA BIOPHARMACEUTICALS INC - JUBILANT TO PROVIDE CO
WITH $19
MILLION IN FORM OF STOCK PURCHASES AND LICENSE FEES
* NAVIDEA BIOPHARMACEUTICALS - IN CONNECTION WITH MOU,
JUBILANT
MADE A $1 MILLION EQUITY INVESTMENT IN CO IN EXCHANGE FOR A
LIMITED EXCLUSIVITY PERIOD
Source text for Eikon: ID:nBw8G19fha
Further company coverage: JULS.NS
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures